Profund Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
24,694
-24,080
-49% -$1.01M 0.04% 277
2026
Q1
$1.57M Buy
48,774
+14,107
+41% +$522K 0.06% 242
2025
Q4
$1.46M Buy
34,667
+11,505
+50% +$464K 0.04% 269
2025
Q3
$795K Buy
23,162
+78
+0.3% +$2.24K 0.03% 379
2025
Q2
$624K Sell
23,084
-328
-1% -$9.5K 0.02% 407
2025
Q1
$694K Buy
23,412
+5,097
+28% +$194K 0.03% 389
2024
Q4
$725K Sell
18,315
-396
-2% -$15K 0.03% 366
2024
Q3
$637K Sell
18,711
-2,370
-11% -$66.7K 0.02% 438
2024
Q2
$457K Sell
21,081
-27,239
-56% -$573K 0.02% 530
2024
Q1
$1.07M Buy
48,320
+21,388
+79% +$522K 0.04% 344
2023
Q4
$741K Sell
26,932
-9,490
-26% -$229K 0.03% 402
2023
Q3
$813K Sell
36,422
-8,237
-18% -$212K 0.05% 334
2023
Q2
$1.14M Sell
44,659
-9,585
-18% -$232K 0.06% 291
2023
Q1
$1.21M Buy
+54,244
New +$1.31M 0.07% 255

Other funds holding VCYT

Profund Advisors's VCYT Position: Q2 2026 in Review

Profund Advisors reduced its Veracyte (VCYT) stake by 49% in Q2 2026, selling an estimated $1.01M and leaving 24,694 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #277.

Profund Advisors first reported a position in VCYT in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.57M in Q1 2026. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Profund Advisors held 24,694 shares of Veracyte worth $1.45M as of Q2 2026.
  • Profund Advisors sold 24,080 Veracyte shares in Q2 2026, an estimated $1.01M.
  • Veracyte made up 0.04% of Profund Advisors's portfolio in Q2 2026, its #277 holding.
  • Profund Advisors first reported a position in Veracyte in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Veracyte position peaked at $1.57M in Q1 2026.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.